Furthermore, both genetic and pharmacological inhibition of USP14 significantly suppressed the growth of AR-reactive breast cancer cells by impeding the G0/G1-S phase transition and inducing apoptosis [19]. This evidence concerns the gene AR and breast carcinoma.